Skip to main content

Blog

Newly Published Study Evaluates Patients’ and Caregivers’ Acceptable Risk from Gene Therapy

...

Avidity Biosciences Announces Positive Pre-BLA Meeting with FDA for del-zota

...

Standing Together for Access: Ensuring Duchenne Patients Can Benefit from Approved Therapies

...

Catch Up on World Muscle Society 2025

...

Building Protection: Vaccines and Dystrophinopathy

...

Catch Up on PPMD Together: Charlotte

...

Ready for Respiratory Season: Keeping You and Your Family Healthy

...

Duchenne on the World Stage: World Duchenne Awareness Day at the United Nations

...

Avidity Biosciences Announces Positive New Data from EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Studies

...

PPMD Kicks Off World Duchenne Awareness Day with Bad Shirt Friday, Special United Nations Documentary Premiere

...